HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zheng Yang Selected Research

2,2-dichloroacetophenone

11/2017Pharmacological synergism of 2,2-dichloroacetophenone and EGFR-TKi to overcome TKi-induced resistance in NSCLC cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zheng Yang Research Topics

Disease

74Neoplasms (Cancer)
03/2022 - 08/2005
22Fibrosis (Cirrhosis)
01/2022 - 01/2014
21Inflammation (Inflammations)
01/2022 - 07/2004
18Cardiomegaly (Heart Hypertrophy)
10/2021 - 01/2014
11Breast Neoplasms (Breast Cancer)
12/2021 - 09/2009
10Hypertrophy
10/2021 - 10/2007
8Hypoxia (Hypoxemia)
10/2022 - 01/2013
8Body Weight (Weight, Body)
01/2022 - 12/2015
7Pain (Aches)
02/2022 - 08/2011
7Neuralgia (Stump Neuralgia)
01/2022 - 01/2019
7Infections
12/2021 - 07/2004
6Diabetic Cardiomyopathies
01/2021 - 11/2015
6Substance-Related Disorders (Drug Abuse)
07/2015 - 07/2007
5Wounds and Injuries (Trauma)
06/2022 - 01/2016
5Carcinogenesis
03/2022 - 12/2010
5Carcinoma (Carcinomatosis)
01/2022 - 08/2005
5Myocardial Infarction
01/2022 - 08/2017
5Melanoma (Melanoma, Malignant)
01/2022 - 04/2012
5Neoplasm Metastasis (Metastasis)
12/2021 - 12/2010
5Nasopharyngeal Carcinoma
12/2021 - 01/2013
5Ischemia
01/2020 - 01/2013
5Osteosarcoma (Osteogenic Sarcoma)
04/2015 - 12/2010
4Obesity
01/2022 - 11/2007
4Heart Failure
01/2022 - 01/2017
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 09/2014
4Cardiovascular Diseases (Cardiovascular Disease)
12/2018 - 10/2007
4Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2017 - 02/2011
4Leukemia
05/2017 - 08/2006
3Graft vs Host Disease (Graft-Versus-Host Disease)
07/2022 - 10/2012
3Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 12/2016
3Cardiotoxicity
01/2022 - 01/2018
3Dyslipidemias (Dyslipidemia)
01/2022 - 04/2019
3COVID-19
10/2021 - 01/2021
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 10/2013
3Hypertension (High Blood Pressure)
05/2020 - 01/2007
3Squamous Cell Carcinoma of Head and Neck
01/2020 - 01/2013
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2019 - 01/2018
3Colorectal Neoplasms (Colorectal Cancer)
07/2018 - 01/2012
3Demyelinating Diseases (Demyelinating Disease)
01/2018 - 10/2016
3Necrosis
07/2017 - 11/2008
3Colitis
03/2016 - 01/2014
3Rheumatoid Arthritis
09/2015 - 11/2009
3Ulcerative Colitis
01/2015 - 01/2014
3Osteogenesis Imperfecta (Lobstein Disease)
06/2009 - 01/2006
2Sleep Initiation and Maintenance Disorders (Insomnia)
07/2022 - 07/2008

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2004
11Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2005
11CollagenIBA
10/2019 - 06/2009
10Biological ProductsIBA
03/2022 - 06/2012
10Pharmaceutical PreparationsIBA
01/2022 - 08/2005
8MicroRNAs (MicroRNA)IBA
01/2022 - 06/2012
8EnzymesIBA
02/2021 - 01/2007
7Messenger RNA (mRNA)IBA
01/2022 - 06/2011
6Oxygen (Dioxygen)IBA
10/2022 - 10/2014
5Circular RNAIBA
01/2022 - 01/2020
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 11/2015
5Phosphotransferases (Kinase)IBA
12/2021 - 01/2014
5Angiotensin IIIBA
01/2019 - 05/2015
5Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA
11/2018 - 10/2014
5Oxidoreductases (Dehydrogenase)IBA
11/2018 - 01/2013
5ORALIT (ORS)IBA
01/2014 - 12/2013
4Sirtuin 1IBA
01/2022 - 01/2013
4CytokinesIBA
10/2021 - 01/2014
4LigandsIBA
01/2021 - 03/2016
4Peptides (Polypeptides)IBA
01/2021 - 06/2011
4ErbB Receptors (EGF Receptor)IBA
11/2019 - 08/2005
4Tyrosine Kinase InhibitorsIBA
11/2019 - 09/2009
4LipopolysaccharidesIBA
03/2018 - 07/2004
4Interleukin-6 (Interleukin 6)IBA
07/2017 - 11/2011
4Caspase 3 (Caspase-3)IBA
01/2017 - 12/2009
3Therapeutic UsesIBA
10/2022 - 06/2016
3LipidsIBA
01/2022 - 11/2007
3Sirtuin 3IBA
01/2022 - 01/2017
3VaccinesIBA
09/2021 - 05/2013
3myricetinIBA
01/2021 - 01/2017
3Triglycerides (Triacylglycerol)IBA
01/2021 - 08/2018
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2020 - 09/2009
3Anti-Bacterial Agents (Antibiotics)IBA
10/2019 - 12/2007
3AldehydesIBA
01/2019 - 01/2013
3Fingolimod Hydrochloride (FTY720)FDA Link
01/2019 - 03/2016
3AntigensIBA
04/2018 - 04/2012
3Collagen Type I (Type I Collagen)IBA
06/2009 - 01/2006
3S100A12 ProteinIBA
05/2008 - 01/2007
2CholesterolIBA
09/2022 - 01/2022
2Dihydrotachysterol (AT 10)IBA
07/2022 - 11/2009
2Long Noncoding RNAIBA
01/2022 - 01/2020
2AcidsIBA
01/2022 - 01/2016
2Interleukin-10 (Interleukin 10)IBA
01/2022 - 01/2014
2Polysaccharides (Glycans)IBA
01/2022 - 08/2018
2Streptozocin (Streptozotocin)FDA Link
12/2021 - 06/2016
2Matrix Metalloproteinases (MMPs)IBA
12/2021 - 10/2007
2ProdrugsIBA
11/2021 - 01/2021

Therapy/Procedure

38Therapeutics
01/2022 - 06/2006
9Aftercare (After-Treatment)
02/2022 - 04/2007
8Immunotherapy
01/2022 - 04/2012
5Lasers (Laser)
04/2021 - 08/2011
3Drug Therapy (Chemotherapy)
01/2022 - 12/2016
3Radiotherapy
09/2021 - 10/2018
3Oral Administration
12/2018 - 07/2004
2Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2022 - 04/2019